Abstract Library

#1926 Long-Term Outcomes and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs): An Update of a Large National Registry (RGETNE)

Introduction: RGETNE is a national hospital-based GEP-NENs registry coordinated by the Spanish multidisciplinary scientific society GETNE.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Jimenez-Fonseca P, Castaño A, Pi Barrio J, Alonso V, Custodio A,

Keywords: Multivariate, neuroendocrine tumor, prognostic factors, registry, survival, univariate,

#709 Temozolomide and Capecitabine: An Effective Combination in Metastasic G2 NETs

Introduction: Treatment of neuroendocrine tumors (NETs) with chemotherapy has been validated in different studies. Recently a retrospective trial demonstrated high and durable response rate with Temozolomide and Capecitabine in 30 pancreatic NETs (pNETs).

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Barrio M, García R, Garcia E, Medina K, Arbeloa B,

Keywords: neuroendocrine, temozolomide, capecitabine,